Proteomic Analysis of Breast Cancer Tissues to Identify Biomarker Candidates by Gel-Assisted Digestion and Label-Free Quantification Methods Using LC-MS/MS

다국어 초록 (Multilingual Abstract)

This study presents a proteomic method that differentiates between matched normal and breast tumor tissues from ductal carcinoma in situ (DCIS) and invasive carcinoma from Korean women, to identify biomarker candidates and to understand pathogenesis of breast cancer in protein level. Proteins from tissues obtained by biopsy were extracted by RIPA buffer, digested by the gel-assisted method, and analyzed by nano-UPLC-MS/MS. From proteomic analysis based on label-free quantitation strategy, a non-redundant list of 298 proteins was identified from the normal and tumor tissues, and 244 proteins were quantified using IDEAL-Q software. Hierarchical clustering analysis showed two patterns classified as two groups, invasive carcinoma and DCIS, suggesting a difference between two carcinoma at the protein expression level as expected. Differentially expressed proteins in tumor tissues compared to the corresponding normal tissues were related to three biological pathways: antigen-processing and presentation, glycolysis/gluconeogenesis, and complement and coagulation cascades. Among them, the up-regulation of calreticulin (CRT) and protein disulfide isomerase A3 (PDIA3) was confirmed by Western blot analysis. In conclusion, this study showed the possibility of identifying biomarker candidates for breast cancer using tissues and might help to understand the pathophysiology of this cancer at the protein level.

참고문헌 (Reference)

1 Kenny, P. A., "The morphologies of breast cancer cell lines in threedimensional assays correlate with their profiles of gene expression" 1 : 84-96, 2007

2 Tolle, S. W., "Pyruvate kinase isozymes in neurons, glia, neuroblastoma, and glioblastoma" 27 : 1355-1360, 1976

3 Schering, B., "Purification and properties of pyruvate kinase type M2 from rat lung" 717 : 337-347, 1982

4 Corcoran, E., "Purification and properties of pyruvate kinase from human lung" 446 : 96-104, 1976

5 Moon, P. G., "Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy" WILEY-BLACKWELL 11 (11): 2459-2475, 201106

6 Bianchi, L., "Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L gene induction" 5 : 2433-2442, 2005

7 Bini, L., "Protein expression profiles in human breast ductal carcinoma and histologically normal tissue" 18 : 2832-2841, 1997

8 Alaiya, A., "Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma" 21 : 1-9, 2000

9 Macdonald, M. J., "Pancreatic islets contain the M2 isoenzyme of pyruvate kinase. Its phosphorylation has no effect on enzyme activity" 68 : 115-120, 1985

10 Polyak, K., "On the birth of breast cancer" 1552 : 1-13, 2001

11 Yoon, G. S., "Nuclear matrix of calreticulin in hepatocellular carcinoma" 60 : 1117-1120, 2000

12 Beckmann, M. W., "Multistep carcinogenesis of breast cancer and tumour heterogeneity" 75 : 429-439, 1997

13 Hendershot, L. M., "Localization of the gene encoding human BiP/GRP78, the endoplasmic reticulum cognate of the HSP70 family, to chromosome 9q34" 20 : 281-284, 1994

14 Burke, R. E., "Lactate dehydrogenase in estrogen-responsive human breast cancer cells" 38 : 2773-2776, 1978

15 Brinck, U., "L-and M2-pyruvate kinase expression in renal cell carcinomas and their metastases" 424 : 177-185, 1994

16 Ostwald, T. J., "Isolation of a high affinity calcium-binding protein from sarcoplasmic reticulum" 249 : 974-979, 1974

17 Heal, R., "Induction of calreticulin expression in response to amino acid deprivation in Chinese hamster ovary cells" 329 (329): 389-394, 1998

18 Cho, Y. E., "In-depth identification of pathways related to cisplatininduced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach" 11 : 2012

19 Garbi, N., "Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57" 7 : 93-102, 2006

20 Reinacher, M., "Immunohistological demonstration of the same type of pyruvate kinase isoenzyme(M2-Pk)in tumors of chicken and rat" 37 : 79-88, 1981

21 Janeway, C., "Immunobiology : the immune system in health and disease" Garland Scienc 2005

22 Sutton, C. W., "Identification of myocardial proteins from two-dimensional gels by peptide mass fingerprinting" 16 : 308-316, 1995

23 Yu, L. R., "Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry" 21 : 3058-3068, 2000

24 Tsou, C. C., "IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation" 9 : 131-144, 2010

25 Ting, J., "Human gene encoding the 78, 000-dalton glucose-regulated protein and its pseudogene : structure, conservation, and regulation" 7 : 275-286, 1988

26 Conway, E. M., "Heat shock-sensitive expression of calreticulin. In vitro and in vivo up-regulation" 270 : 17011-17016, 1995

27 Parkin, D. M., "Global cancer statistics, 2002" 55 : 74-108, 2005

28 Truong, K., "Evidence for in vitro selection during cell culturing of breast cancer : detection by flow and image cytometry" 114 : 154-155, 1999

29 Keun-YoungYoo, "Epidemiology of Breast Cancer in Korea: Occurrence, High-Risk Groups, and Prevention" 대한의학회 17 (17): 1-6, 2002

30 Ramsamooj, P., "Enhanced expression of calreticulin in the nucleus of radioresistant squamous carcinoma cells in response to ionizing radiation" 55 : 3016-3021, 1995

31 Son, B. H., "Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years" 141 : 155-160, 2006

32 Russo, J., "Cellular basis of breast cancer susceptibility" 11 : 169-178, 1999

33 Michalak, M., "Calreticulin : one protein, one gene, many functions" 344 (344): 281-292, 1999

34 Bouchal, P., "Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry(iTRAQ-2DLC-MS/MS)based quantitative proteomic analysis" 8 : 362-373, 2009

35 Franzen, B., "Analysis of polypeptide expression in benign and malignant human breast lesions : down-regulation of cytokeratins" 74 : 1632-1638, 1996

36 Han, C. L., "A multiplexed quantitative strategy for membrane proteomics : opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease" 7 : 1983-1997, 2008